Selecta Biosciences Merges With Cartesian Therapeutics In All-stock Deal

Selecta Biosciences, Inc. (SELB) announced Monday that it has merged with biotechnology company Cartesian Therapeutics, Inc. In connection with the merger, Selecta announced a $60.

Related Keywords

Timothy Springer ,Carrie Cox ,Murat Kalayoglu ,Carsten Brunn ,Blaine Davis ,Company Nasdaq ,Cartesian Therapeutics Inc ,Selecta Biosciences Inc ,Cartesian Co ,Selecta Biosciences ,Cartesian Therapeutics ,Selecta Board ,Chief Executive Officer Carsten Brunn ,Chief Financial Officer Blaine Davis ,Selecta Chairman Carrie Cox ,Cartesian Co Founders Murat Kalayoglu ,Selecta Series ,Non Voting Convertible Preferred ,Shelb ,